Would that be the top pick of 2020 ? Exelixis shows strong balance sheet plus the growth potential from further expansion. Stock Mover - Exelixis Further Expands Prostate Cancer Cohort in Phase 1b - Exelixis to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020